New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Clinical trial NCT06622434 · RECRUITING

Trial details

NCT number: NCT06622434
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Newly Diagnosed Glioblastoma

Start date: 2024-11-08
Primary completion: 2028-03-08
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.